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Snake venoms comprise a complex mixture of macromolecules, primarily
proteins, that can cause cataclysmic destructive changes to living tissues when
injected by a snake. Somewhat enigmatically, these same molecules have high
potential for medicinal purposes, because most venom components are mimics
of natural regulators of body functions. Previous studies have revealed that
serine proteases in venoms interact with the blood coagulation cascade, a
complex series of protease-mediated reactions in the body which regulate and
the thrombin-like serine proteases (TLSP) act preferentially on fibrinogen. The
isolation and manipulation of these proteins could directly contribute to the
treatment of clotting disorders, acute hypertension, and even some cancers. New
drug candidates are necessary because current drugs have undesired side effects
and several newer candidates have recently failed in clinical trials. To address
this need, I am examining TLSPs from the venom of the Yucatan Rattlesnake
(Crotalus simus tzabcan), a species whose venom has not been investigated but
which contains abundant serine proteases. Isolation of a TLSP has just been
completed using a three step chromatographic purification protocol (low
pressure size exclusion, ion exchange and reversed phase). Initial
characterization of this purified protein include determination of its mass,
specific activity and possible inhibitors. In addition, I will evaluate other physical
characteristics of the protein such as extent of glycosylation, which can influence
physiological stability and resistance to endogenous proteases, and specific
activity toward fibrinogen and other natural substrates. Identification of these
properties are the first steps toward a future therapeutic, and if these are
positive, biological testing in a rodent model will be undertaken. This research
further demonstrates the potential for new and more specific-acting drugs from
natural sources, and animal venoms contain a wealth of candidate molecules
potentially useful for treating human diseases.
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